1. Home
  2. RGA vs VTRS Comparison

RGA vs VTRS Comparison

Compare RGA & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reinsurance Group of America Incorporated

RGA

Reinsurance Group of America Incorporated

SELL

Current Price

$256.09

Market Cap

16.3B

Sector

Finance

ML Signal

SELL

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$17.38

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGA
VTRS
Founded
1973
1961
Country
United States
United States
Employees
N/A
30000
Industry
Life Insurance
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
18.7B
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
RGA
VTRS
Price
$256.09
$17.38
Analyst Decision
Buy
Buy
Analyst Count
10
12
Target Price
★ $277.56
$19.70
AVG Volume (30 Days)
309.7K
★ 7.9M
Earning Date
11-05-2026
11-05-2026
Dividend Yield
1.53%
★ 2.75%
EPS Growth
★ 64.86
N/A
EPS
★ 11.99
0.05
Revenue
★ $23,698,000,000.00
$14,299,900,000.00
Revenue This Year
$13.98
$3.42
Revenue Next Year
$4.59
$1.68
P/E Ratio
★ $21.35
$349.40
Revenue Growth
★ 7.20
N/A
52 Week Low
$178.21
$9.74
52 Week High
$258.53
$18.43

Technical Indicators

Market Signals
Indicator
RGA
VTRS
Relative Strength Index (RSI) 65.47 55.03
Support Level $241.85 $15.94
Resistance Level N/A $18.30
Average True Range (ATR) 5.27 0.50
MACD 0.58 -0.01
Stochastic Oscillator 97.96 39.94

Price Performance

Historical Comparison
RGA
VTRS

About RGA Reinsurance Group of America Incorporated

Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: